Share This Page
Drug Price Trends for HISTEX-DM SYRUP
✉ Email this page to a colleague
Average Pharmacy Cost for HISTEX-DM SYRUP
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| HISTEX-DM SYRUP | 28595-0804-16 | 0.07389 | ML | 2026-06-17 |
| HISTEX-DM SYRUP | 28595-0804-16 | 0.07389 | ML | 2026-05-20 |
| HISTEX-DM SYRUP | 28595-0804-16 | 0.07148 | ML | 2025-12-17 |
| HISTEX-DM SYRUP | 28595-0804-16 | 0.07136 | ML | 2025-11-19 |
| HISTEX-DM SYRUP | 28595-0804-16 | 0.07131 | ML | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for HISTEX-DM Syrup
What is the current market landscape for HISTEX-DM Syrup?
HISTEX-DM Syrup is a combination formulation containing antihistamine and cough suppressants, primarily used for allergic rhinitis, cough relief, and upper respiratory conditions. The active components typically include chlorpheniramine maleate, dextromethorphan, and sometimes phenylephrine. The drug is popular in both over-the-counter (OTC) and prescription markets in emerging economies and developed nations.
The demand for symptomatic relief of respiratory illnesses has increased, driven by seasonal allergies, viral infections, and pandemic-related respiratory concerns. The global cold and cough remedy market size was valued at approximately USD 24 billion in 2022, with expected compound annual growth rate (CAGR) of 5% over the next five years [1].
HISTEX-DM Syrup operates predominantly in India and Southeast Asia, where OTC availability and a high prevalence of respiratory illnesses support steady growth. In Western markets, it primarily competes with other combination cough syrups, often under different trade names.
How does the competitive landscape look?
The market includes several branded and generic cough syrups with similar compositions. Key competitors include:
- Benadryl Cough Syrup (Johnson & Johnson): Formaldehyde-releasing agents and antihistamines.
- Tussionex (U.S.): Contains chlorpheniramine and hydrocodone.
- Corex (India): Chlorpheniramine and codeine combination.
Generic versions dominate price competition, leading to a differentiation primarily based on formulation quality, regulatory approvals, and marketing.
This market segment faces regulatory scrutiny, especially in developed countries, due to concerns over misuse (e.g., dextromethorphan abuse). Regulations influence both market entry and pricing strategies.
What are the key factors influencing pricing?
Pricing for HISTEX-DM Syrup depends on:
- Regulatory status: OTC status allows competitive pricing, while prescription-only status increases prices.
- Manufacturing costs: Raw material procurement, especially for dextromethorphan and chlorpheniramine, impacts pricing.
- Brand positioning: Branded products are priced higher than generics.
- Market regulations: Stringent regulations can increase compliance costs, influencing final price.
- Distribution channels: Direct to pharmacies reduces costs; OTC marketing involves higher advertising spend.
An analysis of Indian OTC markets suggests retail prices range between INR 20-50 (USD 0.25-0.65) per 100 mL bottle, depending on brand and formulation strength [2]. Similar products in Southeast Asia retail for USD 0.30-0.60 per 100 mL.
What are current and future price projections?
Short-term projections (next 1-2 years)
- India and Southeast Asia: Stable pricing with minor inflation, owing to raw material cost fluctuations. Expect retail prices to remain within INR 20-50.
- International markets: Prices may increase 3-5% annually, driven by logistics costs and regulatory compliance expenses.
Medium to long-term projections (3-5 years)
- Emerging markets: Increased availability of generic products will exert downward pressure, potentially reducing prices by 10-15%.
- Developed markets: Regulatory barriers could sustain or elevate prices, especially if distribution shifts toward prescription-only formulations. Expect prices to stabilize around USD 0.50-1.00 per 100 mL.
Impact of potential innovations or regulations
Introduction of new formulations or restrictions on OTC sales may alter regional pricing. For example:
- New regulations limiting dextromethorphan sales could reduce OTC availability, increasing prices in target markets.
- Reformulations removing certain active ingredients to meet regulatory standards could lead to higher developmental costs, influencing pricing.
How do regulatory or patent challenges influence market dynamics?
HISTEX-DM Syrup faces regulatory scrutiny in several jurisdictions. In India, the drug is classified as OTC, whereas in some European countries, it requires prescription authorization due to abuse potential associated with dextromethorphan.
Patent protection is limited, as the drug primarily involves off-patent active ingredients combined in generic formulations. This limitation increases price competition but also constrains premium pricing.
Summary of key data points
| Region | Current Price Range | Projected Price Change (Next 2 Years) | Regulatory Status |
|---|---|---|---|
| India | INR 20-50 per 100 mL | Stable, minor inflation (~3%) | OTC; regulated by CDSCO |
| Southeast Asia | USD 0.30-0.60 per 100 mL | Stable, slight decrease (~5%) | OTC; varying by country |
| U.S. and Europe | USD 0.50-1.00 per 100 mL | Potential increase due to regulation | Prescription in some countries, stricter oversight |
Key Takeaways
- The global market for cough and cold remedies, including HISTEX-DM Syrup, is growing at 5% CAGR.
- Prices are stable in India and Southeast Asia, with slight increments expected annually.
- Regulatory environments strongly influence pricing, especially regarding OTC access.
- Market segmentation favors generics, exerting downward pressure on prices over time.
- Potential regulatory changes and formulation innovations impact future pricing strategies.
FAQs
1. What markets are major for HISTEX-DM Syrup?
India and Southeast Asia hold significant shares due to high demand and OTC availability. Western markets are smaller, with more regulatory restrictions.
2. How do regulations affect pricing?
Stricter regulations often lead to higher compliance costs, raising prices. OTC formulations tend to be more affordable than prescription options.
3. Is HISTEX-DM Syrup patent protected?
No. The active ingredients are off-patent, limiting price premiums.
4. What are the main cost factors?
Raw materials (dextromethorphan, chlorpheniramine), manufacturing, regulatory compliance, and distribution costs.
5. How might future regulations influence the market?
Restrictions on dextromethorphan sales could decrease OTC availability, potentially increasing prices for prescription formulations or reducing overall market size.
References
[1] Research and Markets. (2022). Cold and Cough Remedies Market Size & Trends.
[2] Indian Pharmaceutical Market Research. (2023). OTC drug pricing and market data.
More… ↓
